Short answer
Neuronetics, Inc. (STIM) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.2). Q2 and first-half 2026 financial results announced for periods ended June 30, 2026.
Neuronetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 and first-half 2026 financial results announced for periods ended June 30, 2026
- Press release furnished as Exhibit 99.1, containing the substantive results investors should review
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure frames fiscal 2026 outlook for revenue, expenses, growth, and upcoming quarters as forward-looking
- Greenbrook TMS transaction identified as a key uncertainty affecting business relationships and operating results
- Profitability and liquidity remain material risks given the company’s history of losses, cash-flow goals, and going-concern considerations
- Revenue dependence on NeuroStar system sales and usage heightens exposure to demand, reimbursement, competition, and regulatory developments
- Management disclaims obligation to update projections, increasing reliance on subsequent SEC filings for revised outlooks
Item EX-99.1 · Exhibit EX-99.2
- Q2 revenue $41.6M, up 9.1%, driven by Greenbrook revenue $26.9M, up 16.8%
- NeuroStar revenue declined 2.7% to $14.7M, highlighting continued pressure in the core device business
- Adjusted EBITDA reached $0.3M versus a $5.6M loss, supported by gross-margin expansion to 51.1% and 12% lower operating expenses
- Net loss narrowed to $3.4M, or $0.05 per share, versus $10.1M, or $0.15, while shares outstanding increased
- Cash totaled $25M at June 30 versus $34.1M at December 31; FY2026 guidance targets revenue $160M-$164M and operating cash flow/investing of negative $10.5M-$14.5M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Neuronetics, Inc. 8-K filings
Get the next STIM 8-K as it lands
Follow STIM for push alerts, or ask the research agent what this filing means.